CryoLogyx completed £500k in a seed funding round led by private UK business angels and Wider Oxford Technology Angel Network to support commercialization of cryopreserved cell technology.

Mar 18, 2024•almost 2 years ago

Amount Raised

£500,000

Round Type

seed

WarwickshireBiotechnology

Investors

Wider Oxford Technology Angel NetworkPrivate Uk Business Angels

Description

CryoLogyx, a University of Warwick spinout, announced the completion of an oversubscribed seed funding round, raising £500k GBP from private UK business angels and the Wider Oxford Technology Angel Network (WOTAN). The funding will be used to support commercialization of the company’s innovative cryopreserved cell technology.

Company Information

Company

CryoLogyx

Location

Warwickshire, England, United Kingdom

About

CryoLogyx is an early-stage biotechnology company which is developing frozen ready-to-use cells for the medicines discovery, diagnostics and cell-therapy industries based in Coventry, UK. With our exclusive technology, we are revolutionizing the freezing, storage, and transportation of cells. Our innovation ensures the delivery of viable cells and cell therapies in the preferred format, ready for use whenever our users need them.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends